Argus Health Systems and Elsevier to Present Synergies Between NCPDP, CMS and OPA During Government Programs Summit, March 11 – 13

KANSAS CITY, Mo., March 7, 2013 /PRNewswire/ –

    What:     John Hill, Vice President, Sales and Marketing,
              Argus Health Systems, Inc., a leading independent
              transparent pharmacy benefit administrator, and Kay
              Morgan, Senior Vice President, Drug Products and
              Industry Standards Research and Compliance,
              Elsevier Gold Standard, will discuss synergies
              between NCPDP, CMS and OPA at the Government
              Programs Summit. Hill and Morgan will describe the
              role and process of working with drug compendia;
              provide an overview of pricing, reimbursement and
              distribution; and will address the role of the
              National Council for Prescription Drug Programs
              during physician administration.

              The Government Programs Summit brings together
              branded and generic manufacturers and policy makers
              from each government agency to discuss how
              businesses are affected by current industry
              challenges and changing legislation.

    Where:   Hyatt Regency Baltimore, Baltimore, MD

    When:    Tuesday, March 12, 2013, at 12:15 p.m.

    CONTACT:  To schedule an interview with John Hill, please
              contact Kate Traynor, ktraynor@knbpr.com. To
              schedule an interview with Kay Morgan, please
              contact Christopher Capot, c.capot@elsevier.com.
             ------------------------------------------------

About Argus Health Systems, Inc.
Argus is a leading independent provider of healthcare information management services supporting Commercial, Medicaid, and Medicare Part D, with a business model that provides full disclosure and transparency. Argus serves a wide range of clients and key healthcare organizations, including managed care organizations, pharmacy benefit managers and pharmaceutical manufacturers.

About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby’s Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

SOURCE Argus Health Systems, Inc.